Jun Heo

Dr. Jun Heo

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2020 in Gut and Liver
Verified
Journal Article
Open access
PDF file
HLHyun Jik Lee
Hyun Jik Lee
CCChang Min Cho
Chang Min Cho
JHJun Heo
Jun Heo
MJMin Kyu Jung
Min Kyu Jung
TKTae Nyeun Kim
Tae Nyeun Kim
YLYoonsuk Lee
Yoonsuk Lee
Hyun Jik Lee, Chang Min Cho, Jun Heo, Min Kyu Jung, Tae Nyeun Kim, Kook Hyun Kim, Hyunsoo Kim, Kwang Bum Cho, Ho Gak Kim, Jimin Han, Dong Wook Lee, and Yoon Suk Lee. Gut and Liver 2020;14:257-64. https://doi.org/10.5009/gnl18537

15 May 2021 in Gut and Liver
Verified
Journal Article
Open access
PDF file
YLYoonsuk Lee
Yoonsuk Lee
CCChang Min Cho
Chang Min Cho
KCKwang Bum Cho
Kwang Bum Cho
JHJun Heo
Jun Heo
MJMin Kyu Jung
Min Kyu Jung
HKHyunsoo Kim
Hyunsoo Kim
Yoon Suk Lee, Chang Min Cho, Kwang Bum Cho, Jun Heo, Min Kyu Jung, Sung Bum Kim, Kook Hyun Kim, Tae Nyeun Kim, Dong Wook Lee, Jimin Han, Ho Gak Kim, Daejin Kim, and Hyunsoo Kim. Gut and Liver 2021;15:459-65. https://doi.org/10.5009/gnl19304


1 January 2020 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
BPByunggeon Park
Byunggeon Park
JPJongmin Park
Jongmin Park
JLJae-Kwang Lim
Jae-Kwang Lim
KSKyung Min Shin
Kyung Min Shin
JLJaehee Lee
Jaehee Lee
SCSooyoung Choi
Sooyoung Choi
Park B, et al. Korean J Radiol. 2020 Jul;21:e130. https://doi.org/10.3348/kjr.2020.0567

23 January 2015 in BMC Cancer
Verified
Journal Article
Open access
PDF file
Ki-cheong ParkKi-cheong Park
Ki-cheong Park
JHJun Heo
Jun Heo
JJJeong Yong Jeon
Jeong Yong Jeon
HCHaeji Choi
Haeji Choi
AJA Ra Jo
A Ra Jo
KHKyung Seok Han
Kyung Seok Han
Epigenetic modifications play a critical role in the regulation of all DNA-based processes, such as transcription, repair, and replication. Inappropriate histone modifications can result in dysregulation of cell growth, leading to neoplastic transformation and cell death. Renal tumors have been shown to have a higher global methylation percentage and reduced histone acetylation. Preclinical models have revealed that histone gene modifiers and epigenetic alterations play important roles in renal cell carcinoma (RCC) tumorigenesis. Recently, a novel HDAC inhibitor, N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), has been introduced as an example of a new class of anti-cancer agents. The anti-cancer activity of HNHA and the underlying mechanisms of action remain to be clarified. The MTS assay using a panel of RCC cells was used to evaluate the anti-proliferative effects of HNHA. The established HDAC inhibitors, SAHA and TSA, were used for comparison. Western blotting analysis was performed to investigate the acetylation of histone H3 and the expression of apoptotic markers in vitro and in vivo. Subcellular fractionation was performed to evaluate expression of Bax and cytochrome c in the cytosol and mitochondria, and also translocation of cytochrome c from the cytoplasm to the nucleus. A confocal microscopic evaluation was performed to confirm inhibition of cell proliferation, induction of apoptosis, and the nuclear translocation of cytochrome c in RCC cells. In this study, we investigated the apoptosis-inducing activity of HNHA in cultured kidney cancer cells. Apoptosis in the HNHA-treated group was induced significantly, with marked caspase activation and Bcl-2 suppression in RCC cells in vitro and in vivo. HNHA treatment caused cytochrome c release from mitochondria, which was mediated by increased Bax expression and caspase activation. HNHA also induced nuclear translocation of cytochrome c, suggesting that HNHA can induce caspase-independent nuclear apoptosis in RCC cells. An in vivo study showed that HNHA had greater anti-tumor and pro-apoptotic effects on RCC xenografts than the established HDAC inhibitors. HNHA has more potent anti-tumor activity than established HDAC inhibitors. Its activities are mediated by caspase-dependent and cytochrome-c-mediated apoptosis in RCC cells. These results suggest that HNHA may offer a new therapeutic approach to RCC.

20 August 2022 in Medicina
Verified
Journal Article
Open access
PDF file
DLDong Wook Lee
Dong Wook Lee
HKHo Gak Kim
Ho Gak Kim
CCChang Min Cho
Chang Min Cho
MJMin Kyu Jung
Min Kyu Jung
JHJun Heo
Jun Heo
HKHyunsoo Kim
Hyunsoo Kim
Background and Objectives: Acute peripancreatic fluid collection (APFC) is an acute local complication of acute pancreatitis (AP) according to the revised Atlanta classification. Sometimes APFC resolves completely, sometimes it changes into a pseudocyst or walled-off necrosis (WON), so called late complications. The aim of this study is to investigate the natural course of APFC detected on early computed tomography (CT) in moderately severe (MSAP) or severe AP (SAP). Materials and Methods: From October 2014 to September 2015, patients with MSAP or SAP were enrolled if there was APFC within 48 h of onset on imaging studies at six medical centers. The status of fluid collection was followed 4–8 weeks after onset. Initial laboratory findings, CT findings and clinical scoring systems were analyzed. Results: A total of 68 patients were enrolled and APFC was completely resolved in 32 (66.7%) patients in the MSAP group and 9 (34.6%) in the SAP group. Patients with a high bedside index for severity in acute pancreatitis (BISAP) score (≥3 points) were common in the SAP group. C-reactive protein (CRP) after 48 h from admission and BUN level were also high in the SAP group. In multivariate analysis, BISAP score (≥3 points), elevation of CRP after 48 h (≥150 mg/L) and nasojejunal feeding after 48 h were risk factors for the development of late complications. Conclusions: Spontaneous resolution of APFC was more common in MSAP group and APFC can be changed to pseudocyst or WON in patients with elevated BISAP score, CRP level after 48 h, and non-improved abdominal pain.